SHARPS TECHNOLOGY INC (STSS) Stock Price, Quote, News and Overview
NASDAQ:STSS - Nasdaq - US82003F2002 - Common Stock - Currency: USD
STSS Quote, Performance and Key Statistics
0.032
+0.01 (+20.75%)
The current stock price of STSS is 0.032 USD. In the past month the price decreased by -87.5%. In the past year, price decreased by -99.49%.
STSS Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ALC | ALCON INC | 30.34 | 46.24B | ||
| COO | COOPER COS INC/THE | 21.09 | 15.90B | ||
| ALGN | ALIGN TECHNOLOGY INC | 18.35 | 12.55B | ||
| SOLV | SOLVENTUM CORP | 9.9 | 11.46B | ||
| LNTH | LANTHEUS HOLDINGS INC | 14.94 | 6.94B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 26.12 | 5.37B | ||
| BLCO | BAUSCH + LOMB CORP | 19.45 | 4.26B | ||
| ICUI | ICU MEDICAL INC | 22.29 | 3.41B | ||
| HAE | HAEMONETICS CORP/MASS | 13.52 | 2.87B | ||
| XRAY | DENTSPLY SIRONA INC | 7.68 | 2.56B | ||
| UFPT | UFP TECHNOLOGIES INC | 27.77 | 1.62B | ||
| NEOG | NEOGEN CORP | 11.55 | 952.81M |
Related stock screener links
About STSS
Company Profile
Sharps Technology, Inc. is a medical device and pharmaceutical packaging company, which engages in the development and manufacturing of innovative drug delivery systems. The company is headquartered in Melville, New York. The company went IPO on 2022-04-14. The firm is engaged in offering patented smart-safety syringe products to the healthcare industry. The firm's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. The company Sharps Securegard and Sologard, and Roncadelle SafeR safety syringe product lines incorporate both active and passive safety features and have been designed to address the three primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. The company also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. The company has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.
Company Info
SHARPS TECHNOLOGY INC
105 Maxess Road, Ste. 124
Melville NEW YORK US
Employees: 57
Company Website: https://sharpstechnology.com/
Investor Relations: https://sharpstechnology.com/investors/
Phone: 15162464000
SHARPS TECHNOLOGY INC / STSS FAQ
What is the stock price of SHARPS TECHNOLOGY INC today?
The current stock price of STSS is 0.032 USD. The price increased by 20.75% in the last trading session.
What is the ticker symbol for SHARPS TECHNOLOGY INC stock?
The exchange symbol of SHARPS TECHNOLOGY INC is STSS and it is listed on the Nasdaq exchange.
On which exchange is STSS stock listed?
STSS stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for SHARPS TECHNOLOGY INC stock?
7 analysts have analysed STSS and the average price target is 359.04 USD. This implies a price increase of 1121900% is expected in the next year compared to the current price of 0.032. Check the SHARPS TECHNOLOGY INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is SHARPS TECHNOLOGY INC worth?
SHARPS TECHNOLOGY INC (STSS) has a market capitalization of 522.56K USD. This makes STSS a Nano Cap stock.
How many employees does SHARPS TECHNOLOGY INC have?
SHARPS TECHNOLOGY INC (STSS) currently has 57 employees.
Is SHARPS TECHNOLOGY INC (STSS) expected to grow?
The Revenue of SHARPS TECHNOLOGY INC (STSS) is expected to grow by 214.37% in the next year. Check the estimates tab for more information on the STSS EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy SHARPS TECHNOLOGY INC (STSS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of STSS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of STSS, evaluating the profitability, health, valuation and growth aspects
- SHARPS TECHNOLOGY INC (STSS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- SHARPS TECHNOLOGY INC (STSS) Sales and EPS estimates to see what analysts future expectations are.
- SHARPS TECHNOLOGY INC (STSS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- SHARPS TECHNOLOGY INC (STSS) Insider and Institutional Ownership to learn about the owners and their transactions.
- SHARPS TECHNOLOGY INC (STSS) Stock Chart to make your own analysis
- SHARPS TECHNOLOGY INC (STSS) Latest news and press-releases to stay up to date.
Does SHARPS TECHNOLOGY INC (STSS) stock pay dividends?
STSS does not pay a dividend.
What is the Price/Earnings (PE) ratio of SHARPS TECHNOLOGY INC (STSS)?
SHARPS TECHNOLOGY INC (STSS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-8.37).
What is the Short Interest ratio of SHARPS TECHNOLOGY INC (STSS) stock?
The outstanding short interest for SHARPS TECHNOLOGY INC (STSS) is 9.64% of its float. Check the ownership tab for more information on the STSS short interest.
STSS Technical Analysis
STSS Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to STSS. STSS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
STSS Financial Highlights
Over the last trailing twelve months STSS reported a non-GAAP Earnings per Share(EPS) of -8.37. The EPS decreased by -1113.77% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -69.94% | ||
| ROE | -120.99% | ||
| Debt/Equity | 0 |
STSS Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to STSS. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 99.03% and a revenue growth 214.37% for STSS